Coronavirus

COVID-19 in 2021: Is it the major disrupter that eHealth needs?

Deborah Claire Saltman   
doi: 10.31128/AJGP-COVID-47   |    Download article
Cite this article    BIBTEX    REFER    RIS

ArticleImage

The COVID-19 pandemic has been a major healthcare disrupter. In disruption’s wake, COVID-19 also has precipitated a new range of activities, including expanding the content, context and funding of telehealth. This article will explore how electronic healthcare (eHealth) delivery has changed in the wake of the global pandemic and suggest some new ways forward.

The diminishing physical aspect of the clinician–patient interaction has been evident for some time, leading not only to increasing telehealth consultations, but also to patients increasingly seeking their own healthcare solutions online.1 ‘Health’ is the second most frequently searched term in Google, accounting for 57% of the more than two trillion searches in 2016. Currently, there are more than 300,000 health apps listed on the internet. If you looked at one per day, it would take more than 800 years to review them all.

Unfortunately, quantity does not necessarily equate with quality. Patients are often bewildered by content and lured by the promise of user-friendliness. During isolation, increased use of health apps persists, even though they deliver much less than they promise. A systematic review of 23 trials of health apps that promised a specific outcome, such as losing weight, showed a meaningful result in fewer than half of them, and most of the trials were only small studies over short periods of time.2

For-profit eHealth apps typically focus on frequently occurring conditions. Examples include single topic areas that have been well researched, such as diabetes or hypertension. Even then, out-of-date information, inaccessible or expired sites, and lack of supporting references and author information are common. The limitations of some men’s health apps and sites are well documented. For example, only one in four prostate cancer websites identified the author of the information.3 More than half had no references; when references were provided, fewer than a quarter cited were reliable. Half of recently reviewed health apps for gout were either no longer available to download or had not been updated since their release (over a year or more before).4

Poor health apps can have unintended consequences for underserved or marginalised populations.5 For example, people living with disabilities and chronic illnesses spend more time online with apps than their abled counterparts and caregivers.6 eHealth apps require regulation, and regulators and global health agencies are beginning to turn their attention to these apps. Increased activity is warranted.

On the other side of the eHealth coin are telehealth consultations. In 2020, the Australian Government introduced a range of telehealth services to the Medicare Benefits Schedule. Some of the services, as seen in the rest of world, were not based on any real evidence of need and additional benefit (eg services to people with eating disorders and children with autism). Other services were grounded in some evidence (eg mental health treatment) or fulfilled a public health gap, such as the provision of pre- and post-exposure prophylaxis.

To date, telehealth has focused on talking assessment and therapy. The physical examination component has been limited to home-based measurements such as blood pressure and temperature and gross observational assessments of skin, respiratory rate and musculoskeletal movements.7

More challenging in the pandemic environment is the investigation of other ailments via telehealth, such as sexually transmissible infections. Primary care clinicians who provide these services in environments where the COVID-19 burden is high are already reporting a lack of personal protective equipment; limited supplies, such as swabs, due to categorisation as a ‘nonessential’ service; and limited laboratory services when state health departments maximise COVID-19 testing and private laboratories no longer collect specimens but require them to be delivered by patients.8

Notwithstanding all these issues, flat-screen health is here to stay. Global medical entrepreneurs – such as Babylon Health, bots or macros in electronic medical records – will be taking over diagnostic interviewing.9 This provides an opportunity for a broader range of remote and technical skills. For example, digitised electronic stethoscopes and electrocardiography via smartphones have been on the market for some time.10 Using these remote technologies requires training and supervision not often provided in medical schools and specialty training to urban physicians. Programs of technical training need to be introduced so that telehealth can provide a more complete consultation.

There are many challenges to clinicians undertaking telehealth, and even more to researchers who will need to conduct deep-dive assessments to supplement the growing literature evaluating patient satisfaction and the talking part of telehealth, and to observe and correlate a broader range of technical, diagnostic and therapeutic aspects. Regulators and global health agencies also might consider working on ways to ensure ethical practices and outcomes are maintained.

First published 15 February 2021.

Competing interests: None.
Provenance and peer review: Provenance and peer review: Not commissioned, peer reviewed.
Citation: Saltman DC. COVID-19 in 2021: Is it the major disrupter that eHealth needs? Aust J Gen Pract 2020;50 Suppl 47. doi: 10.31128/AJGP-COVID-47. [ePub ahead of print]
Correspondence to: debsaltman@gmail.com
References
  1. Saltman DC. Is COVID-19 an opportunity to improve virtual leadership? Aust J Gen Pract 2020;49 Suppl 12. doi: 10.31128/AJGP-COVID-12. [ePub ahead of print] Search PubMed
  2. Byambasuren O, Sanders S, Beller E, Glasziou P. Prescribable mHealth apps identified from an overview of systematic reviews. NPJ Digit Med 2018;1:12. doi:10.1038/s41746-018-0021-9. Search PubMed
  3. Kobes K, Harris IB, Regehr G, Tekian A, Ingledew PA. Malignant websites? Analyzing the quality of prostate cancer education web resources. Can Urol Assoc J 2018;12(10):344–50. doi: 10.5489/cuaj.5084. Search PubMed
  4. Kieser A, Dalbeth N, Serlachius A. Keeping up with the applications: Lessons learned evaluating gout apps. Telemed J E Health 2019;25(4):272–73. doi: 10.1089/tmj.2018.0091. Search PubMed
  5. Vázquez A, Jenaro C, Flores N, Bagnato MJ, Pérez MA, Cruz M. E-health interventions for adult and aging population with intellectual disability: A review. Front Psychol 2018;9:2323. doi: 10.3389/fpsyg.2018.02323. Search PubMed
  6. Wingo BC, Yang DD, Davis D, et al. Lessons learned from a blended telephone/e-health platform for caregivers in promoting physical activity and nutrition in children with a mobility disability. Disabil Health J 2020,13(1):100826. doi: 10.1016/j.dhjo.2019.100826. Search PubMed
  7. Benziger CP, Huffman MD, Sweis RN, Stone NJ. The telehealth ten: A guide for a patient-assisted virtual physical examination. Am J Med 2021;134(1):48–51. doi: 10.1016/j.amjmed.2020.06.015. Search PubMed
  8. Napoleon SC, Maynard MA, Almonte A, et al. Considerations for STI clinics during the COVID-19 pandemic. Sex Transm Dis 2020;47(7):431–33. doi: 10.1097/OLQ.0000000000001192. Search PubMed
  9. Babylon. Babylon health. London, UK: Babylon, 2021. Available at www.babylonhealth.com [Accessed 9 February 2021]. Search PubMed
  10. Weinstein RS, Krupinski EA, Doarn CR. Clinical examination component of telemedicine, telehealth, mHealth, and connected health medical practices. Med Clin North Am 2018;102(3):533–44. doi: 10.1016/j.mcna.2018.01.002. Search PubMed

CoronavirusCOVID-19eHealth

Download article